| # | % | |||||
|---|---|---|---|---|---|---|
| 151 | NANOSPHERE INC | 35,379 | 58,000 | 0.00% | ||
| 152 | Juniper Pharmaceuticals Inc | 1,736 | 20,000 | 0.00% | ||
| 153 | VALEANT PHARMACEUTICALS INTL | 100 | 18,000 | 0.00% | Call | |
| 154 | CAPRICOR THERAPEUTICS INC | 4,000 | 16,000 | 0.00% | ||
| 155 | NUVASIVE INC | 252 | 12,000 | 0.00% | ||
| 156 | SPDR SER TR | 100 | 6,000 | 0.00% | Call | |
| 157 | IDERA PHARMACEUTICALS INCORPORATED COM NEW | 1,537 | 5,000 | 0.00% | ||
| 158 | CONATUS PHARMACEUTICALS INC | 425 | 2,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001019056-15-000911, filed 2015.11.17). Although 0001019056-15-000911 is marked by the manager as a New Holdings filing, our automated system processes it as a Restatement filing.
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
